Packaging Trends

Xcelerate Development Services are complete solution services focused on de-risking development and ensuring speed-to-market.

The approval marks the first time a new glass composition has been approved by FDA since the approval of borosilicate glass more than 100 years ago.

The packaging solution works to protect drugs with a 3-Phase Activ-Polymer solution, a technology that is customized for the drug developer’s formulation, offers a broad spectrum of specific drug protection, and oxygen and odor scavenging.

Advanced packaging requirements for parenteral drugs are being met with highly tailored solutions.

The company will debut its new brand name, ALPLApharma, and its new childproof closure, the CRC justONE, at CPhI Worldwide from Nov. 5–7 in Frankfurt, Germany.

The new location was established to ensure uninterrupted support for clients’ trials in both the United Kingdom and Europe if the UK leaves the European Union on Oct. 31, 2019, especially in the event of a no-deal Brexit.

The companies will present the SV model a semi-automatic machine for the inspection of liquid, lyophilized, or powder products in ampoules, vials, cartridges, and pre-filled syringes.

The new Flexi-Cap Prime will be presented at CPhI Worldwide in Frankfurt, Germany, on Nov. 5–7.

The companies will be presenting Push Packs at CPhI Worldwide on Nov. 5–7 in Frankfurt, Germany.

On Wednesday Nov. 6, 2019, Gregor Deutschle and Dr. Nicolas Eon, both from Schott, will share insights into ready-to-use solutions for complex biotech drugs.

Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.

As drug supply chain security is of paramount importance, could radio-frequency identification solutions provide the optimal solution for pharma companies?

Today’s inspection systems catch tinier flaws, manage data, and increasingly rely on artificial intelligence to further boost performance.

The organizers of Pharmapack Europe have revealed their prediction that the drug delivery and healthcare packaging industry will experience significant growth during 2019.

Pharmapack Europe event organizers have released a report titled, ‘European drug delivery and packaging’ that forecasts an increase in innovation from smaller European companies.

The EU FMD deadline is closing in, so now is the time to look beyond the short term.

Active and intelligent packaging technologies benefit brand owners, caregivers, and patients.

Pharmapack Europe expects further increases in innovation across packaging and drug delivery to mirror overall industry trends.

Pharmapack Europe expects further increases in innovation across packaging and drug delivery to mirror overall industry trends.

Traditional glass and polymeric materials compete for market share in primary packaging for parenteral drug products.

Machine vision and optical character recognition technologies enhance inspection of packages and labels.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

Closures that protect solid-dosage drugs and the capping equipment that applies them have new product-protecting features.

The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.

Measurements by a drone-based online pressure monitoring system help identify weak points in the filling line, enabling the process to be optimized.

Glass and plastic are well established primary packaging materials for the pharmaceutical industry but they both have their advantages and disadvantages.

Manufacturers introduce innovations in glass and plastic packaging for injectables.

Manufacturers introduce innovations in glass and plastic packaging for injectables.

Material innovations enhance packaging for injectables. 

Sensors and communication capability support proper usage, improve compliance, and may enable telemedicine.